Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm
Open Access
- 21 September 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 31 (6), 2498-2508
- https://doi.org/10.1007/s00464-016-5252-8
Abstract
Four randomized controlled trials have demonstrated the short-term efficacy and safety of transoral esophagogastric fundoplication (TF) performed with the EsophyX® device in eliminating troublesome gastroesophageal reflux disease (GERD) symptoms in well-selected patient populations. The aim of this study was to assess the durability of these outcomes at 3 years post-procedure.Keywords
This publication has 35 references indexed in Scilit:
- Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literatureSurgical Endoscopy, 2013
- Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practiceSurgical Endoscopy, 2012
- Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcomeSurgical Endoscopy, 2011
- Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerationsSurgical Endoscopy, 2010
- Guidelines for surgical treatment of gastroesophageal reflux diseaseSurgical Endoscopy, 2010
- Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient populationSurgical Endoscopy, 2009
- The rise and fall of antireflux surgery in the United StatesSurgical Endoscopy, 2006
- Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in JapanJournal of Gastroenterology and Hepatology, 2005
- Complications after anti-reflux surgeryBest Practice & Research Clinical Gastroenterology, 2004
- Laparoscopic fundoplicationSurgical Endoscopy, 2001